Crossbow Therapeutics's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Crossbow Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Crossbow Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Early Stage VC | $30.3M | ▮ | ▮ |
| Mar 2023 | Early Stage VC | $37.6M | ▮ | ▮ |
Membership and data by Private Market View
Crossbow Therapeutics valuation
Crossbow Therapeutics's last reported valuation was $125 million in Jul 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Crossbow Therapeutics raised?
Crossbow Therapeutics has raised $198 million in total; 2 of its rounds are on record. The largest on record was a $37.6 million early-stage round in Mar 2023; the most recent was a $30.3 million early-stage round in Sep 2025.
Crossbow Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Sep 2025 ($30.3 million sold to 17 investors).
How Crossbow Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Crossbow Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Crossbow Therapeutics
- What is Crossbow Therapeutics worth?
- Crossbow Therapeutics is valued at $125.0M as of Oct 2026. Crossbow Therapeutics's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- How much has Crossbow Therapeutics raised?
- Crossbow Therapeutics has raised $198.3M in total funding across 2 recorded rounds.
- When did Crossbow Therapeutics last raise?
- Crossbow Therapeutics last raised in Sep 2025 (Early Stage VC), raising $30.3M.